File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status

TitleAntibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status
Authors
Cheung, Ka ShingLam, Lok KaLeung, Wai Keung
Issue Date29-Dec-2022
PublisherKarger Publishers
Citation
Liver Cancer, 2022, v. 12, n. 1, p. 91-92 How to Cite?
DOI: http://dx.doi.org/10.1159/000528824
Persistent Identifierhttp://hdl.handle.net/10722/337008
ISSN
2235-1795
2023 Impact Factor: 11.6
2023 SCImago Journal Rankings: 3.599
ISI Accession Number ID
WOS:000911163600001

 

DC FieldValueLanguage
dc.contributor.authorCheung, Ka Shing-
dc.contributor.authorLam, Lok Ka-
dc.contributor.authorLeung, Wai Keung-
dc.date.accessioned2024-03-11T10:17:20Z-
dc.date.available2024-03-11T10:17:20Z-
dc.date.issued2022-12-29-
dc.identifier.citationLiver Cancer, 2022, v. 12, n. 1, p. 91-92-
dc.identifier.issn2235-1795-
dc.identifier.urihttp://hdl.handle.net/10722/337008-
dc.languageeng-
dc.publisherKarger Publishers-
dc.relation.ispartofLiver Cancer-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleAntibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status-
dc.typeArticle-
dc.identifier.doi10.1159/000528824-
dc.identifier.scopuseid_2-s2.0-85149102175-
dc.identifier.volume12-
dc.identifier.issue1-
dc.identifier.spage91-
dc.identifier.epage92-
dc.identifier.eissn1664-5553-
dc.identifier.isiWOS:000911163600001-
dc.identifier.issnl1664-5553-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats